Potent urea and carbamate inhibitors of soluble epoxide hydrolases.

The soluble epoxide hydrolase (sEH) plays a significant role in the biosynthesis of inflammation mediators as well as xenobiotic transformations. Herein, we report the discovery of substituted ureas and carbamates as potent inhibitors of sEH. Some of these selective, competitive tight-binding inhibitors with nanomolar K(i) values interacted stoichiometrically with the homogenous recombinant murine and human sEHs. These inhibitors enhance cytotoxicity of trans-stilbene oxide, which is active as the epoxide, but reduce cytotoxicity of leukotoxin, which is activated by epoxide hydrolase to its toxic diol. They also reduce toxicity of leukotoxin in vivo in mice and prevent symptoms suggestive of acute respiratory distress syndrome. These potent inhibitors may be valuable tools for testing hypotheses of involvement of diol and epoxide lipids in chemical mediation in vitro or in vivo systems.

[1]  D. Zeldin,et al.  Metabolism of epoxyeicosatrienoic acids by cytosolic epoxide hydrolase: substrate structural determinants of asymmetric catalysis. , 1995, Archives of biochemistry and biophysics.

[2]  B. Hammock,et al.  Bioactivation of leukotoxins to their toxic diols by epoxide hydrolase , 1997, Nature Medicine.

[3]  B. Hilemàn GREENHOUSE GAS ECONOMICS: Cutting CO to comply with the Kyoto Protocol will have economic costs, but the size of the costs is unknown , 1998 .

[4]  E. Dietze,et al.  Inhibition of cytosolic epoxide hydrolase by trans-3-phenylglycidols. , 1991, Biochemical pharmacology.

[5]  B. Hammock,et al.  Chalcone oxides--potent selective inhibitors of cytosolic epoxide hydrolase. , 1982, Archives of biochemistry and biophysics.

[6]  R. Armstrong Kinetic and chemical mechanism of epoxide hydrolase. , 1999, Drug metabolism reviews.

[7]  B. Borhan,et al.  Development of an in situ toxicity assay system using recombinant baculoviruses. , 1996, Biochemical pharmacology.

[8]  B. Hammock,et al.  Molecular cloning and expression of murine liver soluble epoxide hydrolase. , 1993, The Journal of biological chemistry.

[9]  B D Hammock,et al.  Affinity purification of cytosolic epoxide hydrolase using derivatized epoxy-activated Sepharose gels. , 1988, Analytical biochemistry.

[10]  R. Demling The modern version of adult respiratory distress syndrome. , 1995, Annual review of medicine.

[11]  B. Borhan,et al.  Improved radiolabeled substrates for soluble epoxide hydrolase. , 1995, Analytical biochemistry.

[12]  B. Hammock,et al.  cDNA cloning and expression of a soluble epoxide hydrolase from human liver. , 1993, Archives of biochemistry and biophysics.

[13]  T. Ozawa,et al.  Cardiovascular effects of leukotoxin (9, 10-epoxy-12-octadecenoate) and free fatty acids in dogs. , 1988, Cardiovascular research.

[14]  N. Weintraub,et al.  Epoxyeicosatrienoic acids and dihydroxyeicosatrienoic acids are potent vasodilators in the canine coronary microcirculation. , 1998, Circulation research.

[15]  E. Dietze,et al.  Spectrophotometric substrates for cytosolic epoxide hydrolase. , 1994, Analytical biochemistry.

[16]  B D Hammock,et al.  Mechanism of mammalian soluble epoxide hydrolase inhibition by chalcone oxide derivatives. , 1998, Archives of biochemistry and biophysics.

[17]  F. Oesch,et al.  Mammalian epoxide hydrases: inducible enzymes catalysing the inactivation of carcinogenic and cytotoxic metabolites derived from aromatic and olefinic compounds. , 1973, Xenobiotica; the fate of foreign compounds in biological systems.

[18]  G. Prestwich,et al.  Expression and characterization of the recombinant juvenile hormone epoxide hydrolase (JHEH) from Manduca sexta. , 1998, Insect biochemistry and molecular biology.

[19]  Janeric Seidegård,et al.  The role of human glutathione transferases and epoxide hydrolases in the metabolism of xenobiotics. , 1997 .

[20]  G. Spiteller,et al.  Lipid oxidation products in ischemic porcine heart tissue. , 1996, Chemistry and physics of lipids.

[21]  M. Dixon The graphical determination of Km and Ki , 1972 .